Advertisement

Journal of Autism and Developmental Disorders

, Volume 48, Issue 9, pp 3127–3132 | Cite as

A Comparison of Safety and Efficacy of Dexmedetomidine and Propofol in Children with Autism and Autism Spectrum Disorders Undergoing Magnetic Resonance Imaging

  • Kamal AbulebdaEmail author
  • Ryan Louer
  • Riad Lutfi
  • Sheikh Sohail Ahmed
Original Paper

Abstract

Children with autism and autism spectrum disorders have a high incidence of neurologic comorbidities. Consequently, evaluation with magnetic resonance imaging (MRI) is deemed necessary. Sedating these patients poses several challenges. This retrospective study compared the efficacy and safety of dexmedetomidine to propofol in sedating autistic patients undergoing MRI. There were 56 patients in the dexmedetomidine group and 49 in the propofol group. All of the patients successfully completed the procedure. Recovery and discharge times were significantly lower in the propofol group, while the dexmedetomidine group maintained more stable hemodynamics. Both propofol and dexmedetomidine proved to be adequate and safe medications in the sedation of autistic children undergoing MRI.

Keywords

Autism Magnetic resonance imaging Deep sedation Propofol Dexmedetomidine 

Notes

Acknowledgments

The authors have reported that no funding was received for this study.

Author Contributions

KA helped gathering data, conceptualizing and drafting the initial manuscript, and approved the final manuscript as submitted. RL and RL carried out the initial analyses, reviewed and revised the manuscript, and approved the final manuscript as submitted. SSA designed and conceptualized the study, and coordinated and supervised data collection, critically reviewed and approved the final manuscript as submitted.

References

  1. Ahmed, S. S., Unland, T., Slaven, J. E., Nitu, M. E., & Rigby, M. R. (2014). Successful use of intravenous dexmedetomidine for magnetic resonance imaging sedation in autistic children. Southern Medical Journal, 107(9), 559–564.  https://doi.org/10.14423/SMJ.0000000000000160.CrossRefPubMedGoogle Scholar
  2. Berkenbosch, J. W., Wankum, P. C., & Tobias, J. D. (2005). Prospective evaluation of dexmedetomidine for noninvasive procedural sedation in children. Pediatric Critical Care Medicine, 6(4), 435–439.  https://doi.org/10.1097/01.PCC.0000163680.50087.93. quiz 440.CrossRefPubMedGoogle Scholar
  3. Bhana, N., Goa, K. L., & McClellan, K. J. (2000). Dexmedetomidine. Drugs, 59(2), 263–268; discussion 269–270.CrossRefPubMedGoogle Scholar
  4. Canitano, R., Luchetti, A., & Zappella, M. (2005). Epilepsy, electroencephalographic abnormalities, and regression in children with autism. Journal of Child Neurology, 20(1), 27–31.  https://doi.org/10.1177/08830738050200010401.CrossRefPubMedGoogle Scholar
  5. Chakrabarti, S., & Fombonne, E. (2005). Pervasive developmental disorders in preschool children: Confirmation of high prevalence. American Journal of Psychiatry, 162(6), 1133–1141.  https://doi.org/10.1176/appi.ajp.162.6.1133.CrossRefPubMedGoogle Scholar
  6. Chiaretti, A., Benini, F., Pierri, F., Vecchiato, K., Ronfani, L., Agosto, C., … Barbi, E. (2014). Safety and efficacy of propofol administered by paediatricians during procedural sedation in children. Acta Paediatrica, 103(2), 182–187.  https://doi.org/10.1111/apa.12472.CrossRefPubMedGoogle Scholar
  7. Coté, C. J., Wilson, S., PEDIATRICS, A. A. O., & DENTISTRY, A. A. O. P. (2016). Guidelines for monitoring and management of pediatric patients before, during, and after sedation for diagnostic and therapeutic procedures: Update 2016. Pediatrics.  https://doi.org/10.1542/peds.2016-1212.Google Scholar
  8. Coté, C. J., Wilson, S., Pediatrics, A. A. o., Dentistry, A. A. o., P., & Sedation, W. G. o. (2006). Guidelines for monitoring and management of pediatric patients during and after sedation for diagnostic and therapeutic procedures: An update. Pediatrics, 118(6), 2587–2602.  https://doi.org/10.1542/peds.2006-2780.CrossRefPubMedGoogle Scholar
  9. Cravero, J. P., Beach, M. L., Blike, G. T., Gallagher, S. M., Hertzog, J. H., & Consortium, P. S. R. (2009). The incidence and nature of adverse events during pediatric sedation/anesthesia with propofol for procedures outside the operating room: A report from the Pediatric Sedation Research Consortium. Anesthesia & Analgesia, 108(3), 795–804.  https://doi.org/10.1213/ane.0b013e31818fc334.CrossRefGoogle Scholar
  10. Deegan, R. J. (1992). Propofol: A review of the pharmacology and applications of an intravenous anesthetic agent. American Journal of the Medical Sciences, 304(1), 45–49.CrossRefPubMedGoogle Scholar
  11. Diagnostic and Statistical Manual of Mental Disorders. (2000). Diagnostic and statistical manual of mental disorders (4th ed.). Washington, DC: American Psychiatric Association.Google Scholar
  12. Disabilities, C. o. C. W., Pediatrics, S. o. D. B., Committee, B. F. S., & Committee, M. H. I. f. C. W. S. N. P. A. (2006). Identifying infants and young children with developmental disorders in the medical home: An algorithm for developmental surveillance and screening. Pediatrics, 118(1), 405–420.  https://doi.org/10.1542/peds.2006-1231.CrossRefGoogle Scholar
  13. Dyck, J. B., Maze, M., Haack, C., Vuorilehto, L., & Shafer, S. L. (1993). The pharmacokinetics and hemodynamic effects of intravenous and intramuscular dexmedetomidine hydrochloride in adult human volunteers. Anesthesiology, 78(5), 813–820.CrossRefPubMedGoogle Scholar
  14. Gutstein, H. B., Johnson, K. L., Heard, M. B., & Gregory, G. A. (1992). Oral ketamine preanesthetic medication in children. Anesthesiology, 76(1), 28–33.CrossRefPubMedGoogle Scholar
  15. Heard, C., Burrows, F., Johnson, K., Joshi, P., Houck, J., & Lerman, J. (2008). A comparison of dexmedetomidine-midazolam with propofol for maintenance of anesthesia in children undergoing magnetic resonance imaging. Anesthesia & Analgesia, 107(6), 1832–1839.  https://doi.org/10.1213/ane.0b013e31818874ee.CrossRefGoogle Scholar
  16. Hertzog, J. H., Dalton, H. J., Anderson, B. D., Shad, A. T., Gootenberg, J. E., & Hauser, G. J. (2000). Prospective evaluation of propofol anesthesia in the pediatric intensive care unit for elective oncology procedures in ambulatory and hospitalized children. Pediatrics, 106(4), 742–747.CrossRefPubMedGoogle Scholar
  17. Kallio, A., Scheinin, M., Koulu, M., Ponkilainen, R., Ruskoaho, H., Viinamäki, O., & Scheinin, H. (1989). Effects of dexmedetomidine, a selective alpha 2-adrenoceptor agonist, on hemodynamic control mechanisms. Clinical Pharmacology & Therapeutics, 46(1), 33–42.CrossRefGoogle Scholar
  18. Kamat, P. P., McCracken, C. E., Gillespie, S. E., Fortenberry, J. D., Stockwell, J. A., Cravero, J. P., & Hebbar, K. B. (2015). Pediatric critical care physician-administered procedural sedation using propofol: A report from the Pediatric Sedation Research Consortium Database. Pediatric Critical Care Medicine, 16(1), 11–20.  https://doi.org/10.1097/PCC.0000000000000273.CrossRefPubMedGoogle Scholar
  19. Kanto, J., & Gepts, E. (1989). Pharmacokinetic implications for the clinical use of propofol. Clinical Pharmacokinetics, 17(5), 308–326.  https://doi.org/10.2165/00003088-198917050-00002.CrossRefPubMedGoogle Scholar
  20. Koroglu, A., Demirbilek, S., Teksan, H., Sagir, O., But, A. K., & Ersoy, M. O. (2005). Sedative, haemodynamic and respiratory effects of dexmedetomidine in children undergoing magnetic resonance imaging examination: preliminary results. Br J Anaesth, 94(6), 821–824.  https://doi.org/10.1093/bja/aei119.CrossRefPubMedGoogle Scholar
  21. Koroglu, A., Teksan, H., Sagir, O., Yucel, A., Toprak, H. I., & Ersoy, O. M. (2006). A comparison of the sedative, hemodynamic, and respiratory effects of dexmedetomidine and propofol in children undergoing magnetic resonance imaging. Anesthesia & Analgesia, 103(1), 63–67.  https://doi.org/10.1213/01.ANE.0000219592.82598.AA.CrossRefGoogle Scholar
  22. Kotani, Y., Shimazawa, M., Yoshimura, S., Iwama, T., & Hara, H. (2008). The experimental and clinical pharmacology of propofol, an anesthetic agent with neuroprotective properties. CNS Neuroscience & Therapeutics, 14(2), 95–106.  https://doi.org/10.1111/j.1527-3458.2008.00043.x.CrossRefGoogle Scholar
  23. Krauss, B., & Green, S. M. (2006). Procedural sedation and analgesia in children. Lancet, 367(9512), 766–780.  https://doi.org/10.1016/S0140-6736(06)68230-5.CrossRefPubMedGoogle Scholar
  24. Lubisch, N., Roskos, R., & Berkenbosch, J. W. (2009). Dexmedetomidine for procedural sedation in children with autism and other behavior disorders. Pediatric Neurology, 41(2), 88–94.  https://doi.org/10.1016/j.pediatrneurol.2009.02.006.CrossRefPubMedGoogle Scholar
  25. Mason, K. P., Sanborn, P., Zurakowski, D., Karian, V. E., Connor, L., Fontaine, P. J., & Burrows, P. E. (2004). Superiority of pentobarbital versus chloral hydrate for sedation in infants during imaging. Radiology, 230(2), 537–542.  https://doi.org/10.1148/radiol.2302030107.CrossRefPubMedGoogle Scholar
  26. Mason, K. P., Zgleszewski, S. E., Dearden, J. L., Dumont, R. S., Pirich, M. A., Stark, C. D., … Zurakowski, D. (2006). Dexmedetomidine for pediatric sedation for computed tomography imaging studies. Anesthesia & Analgesia, 103(1), 57–62.  https://doi.org/10.1213/01.ane.0000216293.16613.15.CrossRefGoogle Scholar
  27. Mehta, U. C., Patel, I., & Castello, F. V. (2004). EEG sedation for children with autism. Journal of Developmental & Behavioral Pediatrics, 25(2), 102–104.CrossRefGoogle Scholar
  28. Myers, S. M., Johnson, C. P., & Disabilities, A. A. o. P. C. o. C. W. (2007). Management of children with autism spectrum disorders. Pediatrics, 120(5), 1162–1182.  https://doi.org/10.1542/peds.2007-2362.CrossRefPubMedGoogle Scholar
  29. Rainey, L., & van der Walt, J. H. (1998). The anaesthetic management of autistic children. Anaesth Intensive Care, 26(6), 682–686.PubMedGoogle Scholar
  30. Seid, M., Sherman, M., & Seid, A. B. (1997). Perioperative psychosocial interventions for autistic children undergoing ENT surgery. International Journal of Pediatric Otorhinolaryngology, 40(2–3), 107–113.CrossRefPubMedGoogle Scholar
  31. Shelly, M. P. (2001). Dexmedetomidine: a real innovation or more of the same? British Journal of Anaesthesia, 87(5), 677–678.CrossRefPubMedGoogle Scholar
  32. Sulton, C., McCracken, C., Simon, H. K., Hebbar, K., Reynolds, J., Cravero, J., … Kamat, P. (2016). Pediatric procedural sedation using dexmedetomidine: A Report From the Pediatric Sedation Research Consortium. Hospital Pediatrics, 6(9), 536–544.  https://doi.org/10.1542/hpeds.2015-0280.CrossRefPubMedGoogle Scholar
  33. Tramèr, M. R., Moore, R. A., & McQuay, H. J. (1997). Propofol and bradycardia: causation, frequency and severity. British Journal of Anaesthesia, 78(6), 642–651.CrossRefPubMedGoogle Scholar
  34. Vardi, A., Salem, Y., Padeh, S., Paret, G., & Barzilay, Z. (2002). Is propofol safe for procedural sedation in children? A prospective evaluation of propofol versus ketamine in pediatric critical care. Critical Care Medicine, 30(6), 1231–1236.CrossRefPubMedGoogle Scholar
  35. Weerink, M. A. S., Struys, M. M. R. F., Hannivoort, L. N., Barends, C. R. M., Absalom, A. R., & Colin, P. (2017). Clinical pharmacokinetics and pharmacodynamics of dexmedetomidine. Clinical Pharmacokinectics, 56(8), 893–913.  https://doi.org/10.1007/s40262-017-0507-7.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Division of Critical Care, Department of Pediatrics, Indiana University School of MedicineRiley Hospital for Children at Indiana University HealthIndianapolisUSA
  2. 2.Department of PediatricsIndiana University School of MedicineIndianapolisUSA

Personalised recommendations